1. Home
  2. DXCM vs GIB Comparison

DXCM vs GIB Comparison

Compare DXCM & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • GIB
  • Stock Information
  • Founded
  • DXCM 1999
  • GIB 1976
  • Country
  • DXCM United States
  • GIB Canada
  • Employees
  • DXCM N/A
  • GIB N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • GIB Professional Services
  • Sector
  • DXCM Health Care
  • GIB Consumer Discretionary
  • Exchange
  • DXCM Nasdaq
  • GIB Nasdaq
  • Market Cap
  • DXCM 28.0B
  • GIB 25.5B
  • IPO Year
  • DXCM 2005
  • GIB N/A
  • Fundamental
  • Price
  • DXCM $77.59
  • GIB $112.66
  • Analyst Decision
  • DXCM Buy
  • GIB Buy
  • Analyst Count
  • DXCM 17
  • GIB 3
  • Target Price
  • DXCM $101.29
  • GIB $136.67
  • AVG Volume (30 Days)
  • DXCM 3.9M
  • GIB 171.4K
  • Earning Date
  • DXCM 10-24-2024
  • GIB 01-29-2025
  • Dividend Yield
  • DXCM N/A
  • GIB N/A
  • EPS Growth
  • DXCM 83.21
  • GIB 6.56
  • EPS
  • DXCM 1.67
  • GIB 5.41
  • Revenue
  • DXCM $3,954,000,000.00
  • GIB $10,863,578,959.00
  • Revenue This Year
  • DXCM $13.10
  • GIB $8.01
  • Revenue Next Year
  • DXCM $14.79
  • GIB $4.21
  • P/E Ratio
  • DXCM $47.33
  • GIB $20.34
  • Revenue Growth
  • DXCM 16.19
  • GIB 2.66
  • 52 Week Low
  • DXCM $62.34
  • GIB $96.92
  • 52 Week High
  • DXCM $142.00
  • GIB $118.89
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 59.79
  • GIB 55.96
  • Support Level
  • DXCM $78.06
  • GIB $111.02
  • Resistance Level
  • DXCM $82.26
  • GIB $113.33
  • Average True Range (ATR)
  • DXCM 2.36
  • GIB 1.68
  • MACD
  • DXCM 0.25
  • GIB 0.37
  • Stochastic Oscillator
  • DXCM 61.69
  • GIB 92.55

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.

Share on Social Networks: